VANCOUVER, BC / ACCESSWIRE / May 7th, 2014 / Auxellence Health Corporation (CSE:AID) (the "Company" or "Auxellence") announces that Mr. Sydney Au, the President, Chief Executive Officer and Chairman of the company, as well as a control block shareholder of Auxellence, has filed Form 45-102F1 on SEDAR as Project No. 02204856 to provide the required notice of his intention to sell shares or option up to 9,000,000 shares that he controls in Auxellence. Mr. Au, currently owns 18,500,000 shares directly and 12,500,000 shares indirectly for a total of 31,000,000 shares representing 73.15% of the company, and indirectly holds $238,500 of convertible debt that can be converted into 1,192,500 shares of the Company.
Contact:
Sydney Au, President & CEO
Auxellence Health Corporation
Email: [email protected]
Phone: (604) 780-3311
About Auxellence Health Corporation
Auxellence is a health technology company that aims to provide high-level online personal health services to consumers, providers and suppliers of OTC (Over-The-Counter) health care products and services, including refining the effectiveness of prescribing services to the OTC (Over-The-Counter) consumer pharmaceutical and natural health industry. The Company is integrating innovative therapeutic and diagnostic (theragnostic) devices (hardware components), along with an interactive Expert System and Recommender "PRESCRIPTOR" engine (software platform) to acquire physiological data for personalized medicine and health solutions to everyday health issues (initially targeting weight management and skin health conditions (acne)).
Disclaimer for Forward-Looking Information Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. Except as required by law, the Company does not intend to update any changes to such statements. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
SOURCE: Auxellence Health Corporation